Bempedoic acid/ezetimibe Interactions
There are 110 drugs known to interact with bempedoic acid/ezetimibe, along with 5 disease interactions. Of the total drug interactions, 31 are major, 75 are moderate, and 4 are minor.
- View all 110 medications that may interact with bempedoic acid/ezetimibe
- View bempedoic acid/ezetimibe disease interactions (5)
Most frequently checked interactions
View interaction reports for bempedoic acid/ezetimibe and the medicines listed below.
- Alcohol (contained in alcoholic beverages) (ethanol)
- Anoro Ellipta (umeclidinium / vilanterol)
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Centrum Silver Women's (multivitamin with minerals)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flonase (fluticasone nasal)
- Gaviscon Regular Strength Tablets (aluminum hydroxide / magnesium trisilicate)
- Glyceryl T (guaifenesin / theophylline)
- Humira (adalimumab)
- Micardis (telmisartan)
- Mounjaro (tirzepatide)
- Mucinex (guaifenesin)
- Nexletol (bempedoic acid)
- Paracetamol (acetaminophen)
- Protonix (pantoprazole)
- Repatha (evolocumab)
- Tapazole (methimazole)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Tresiba (insulin degludec)
- Vitamin A, D (multivitamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zetia (ezetimibe)
- Zortress (everolimus)
Bempedoic acid/ezetimibe disease interactions
There are 5 disease interactions with bempedoic acid/ezetimibe which include:
Report options
QR code containing a link to this page
More about bempedoic acid/ezetimibe
- bempedoic acid/ezetimibe consumer information
- Compare alternatives
- Reviews (15)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: antihyperlipidemic combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
